| Literature DB >> 26403419 |
Oriol Calvete1,2, Paula Martinez3, Pablo Garcia-Pavia4,5, Carlos Benitez-Buelga1, Beatriz Paumard-Hernández1, Victoria Fernandez1, Fernando Dominguez4, Clara Salas6, Nuria Romero-Laorden7, Jesus Garcia-Donas7, Jaime Carrillo8, Rosario Perona2,8, Juan Carlos Triviño9, Raquel Andrés10, Juana María Cano11, Bárbara Rivera12, Luis Alonso-Pulpon4, Fernando Setien13, Manel Esteller13,14,15, Sandra Rodriguez-Perales16, Gaelle Bougeard17, Tierry Frebourg17, Miguel Urioste2,12, Maria A Blasco3, Javier Benítez1,2.
Abstract
Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li-Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121,324 studied alleles in ExAC server but it is not described in any other database or found in 1,520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26403419 PMCID: PMC4598567 DOI: 10.1038/ncomms9383
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694